Filtered news list testing
List of Reports
.pdf
04/20/2023 - Q1 2023 Revenue
.pdf
04/19/2023 - Universal Registration Document 2022
.pdf
03/23/2023 - 2022 Full-year results (Presentation)
.pdf
03/22/2023 - 2022 annual results
.pdf
02/09/2023 - 2022 Revenue
.pdf
01/11/2023 - Intrasense Opens Its Share Capital To The Guerbet Group, Which Announces Its Intent To File A Voluntary Tender Offer Under The Same Price Conditions
.pdf
01/16/2023 - 2023 Strategic Priorities
.pdf
11/03/2022 - Guerbet announces a change in governance for its Artificial Intelligence projects
Single report testing
.pdf
test report fabien V 09-07
Separator
Discover the latest news of Guerbet
Latest news
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
2024 revenue
2024 revenue
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging